-
-
-
-
-
-
-
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin
-
-
-
-
-
-
-
Rhelion Life Sciences Reports First Quarter 2027 Results
-
-
-
-
-
-
-
Rhelion Life Sciences Corp. Commences Trading Under New Name and Ticker Symbol RHEL on the CSE
-
-
-
-
-
-
-
Red Light Holland reports preclinical coca extract results for post-GLP-1 weight management
-
-
-
-
-
-
-
Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intell
-
-
-
-
-
-
-
Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments
-
-
-
-
-
-
-
RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
-
1,192,419 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

